Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ZY4C
|
|||
| Former ID |
DNC014364
|
|||
| Drug Name |
N-phenethyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine
|
|||
| Synonyms |
CHEMBL1082978; N-phenethyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine; BDBM50319973
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H20N4
|
|||
| Canonical SMILES |
C1CCN(C1)C2=NC=CC(=N2)NCCC3=CC=CC=C3
|
|||
| InChI |
1S/C16H20N4/c1-2-6-14(7-3-1)8-10-17-15-9-11-18-16(19-15)20-12-4-5-13-20/h1-3,6-7,9,11H,4-5,8,10,12-13H2,(H,17,18,19)
|
|||
| InChIKey |
MIALFBONYMMUFB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Acetylcholinesterase (AChE) | Target Info | Inhibitor | [1] |
| Cholinesterase (BCHE) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Glycerophospholipid metabolism | |||
| Cholinergic synapse | ||||
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| Pathwhiz Pathway | Phospholipid Biosynthesis | |||
| Pathway Interaction Database | ATF-2 transcription factor network | |||
| WikiPathways | Monoamine Transport | |||
| Biogenic Amine Synthesis | ||||
| Acetylcholine Synthesis | ||||
| Integrated Pancreatic Cancer Pathway | ||||
| Irinotecan Pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design, synthesis and evaluation of 2,4-disubstituted pyrimidines as cholinesterase inhibitors. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3606-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.